Understanding how ligands interact with RNA in cells
Transcriptome Analysis with RNA-Reactive Probes
['FUNDING_OTHER'] · STANFORD UNIVERSITY · NIH-11066548
This study is looking at how certain molecules interact with RNA in our cells to better understand how these interactions affect our health, which could lead to safer and more effective RNA-based treatments for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | STANFORD UNIVERSITY (nih funded) |
| Locations | 1 site (STANFORD, UNITED STATES) |
| Trial ID | NIH-11066548 on ClinicalTrials.gov |
What this research studies
This research investigates the interactions between ligands and various RNA species within cells, aiming to uncover how these interactions influence cellular pathways and health. By developing new molecular tools and methods, the research seeks to analyze RNA interactions on a transcriptome-wide scale, which is crucial for advancing RNA-based therapies. Patients may benefit from insights gained about drug toxicity and the development of improved RNA therapies that could enhance treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could be influenced by RNA-targeted therapies or those experiencing drug-related toxicity.
Not a fit: Patients who do not have conditions related to RNA interactions or who are not undergoing treatment with RNA-targeted therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective RNA-based therapies and a better understanding of drug interactions, ultimately improving patient care.
How similar studies have performed: Previous research has shown promising results in understanding RNA interactions and their implications for health, suggesting that this approach could yield significant advancements.
Where this research is happening
STANFORD, UNITED STATES
- STANFORD UNIVERSITY — STANFORD, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KOOL, ERIC T. — STANFORD UNIVERSITY
- Study coordinator: KOOL, ERIC T.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.